<bill session="117" type="h" number="6625" updated="2022-12-30T04:18:58Z">
  <state datetime="2022-02-07">REFERRED</state>
  <status>
    <introduced datetime="2022-02-07"/>
  </status>
  <introduced datetime="2022-02-07"/>
  <titles>
    <title type="display">Equal Access to Therapeutics Act</title>
    <title type="short" as="introduced">Equal Access to Therapeutics Act</title>
    <title type="official" as="introduced">To prohibit the Secretary of Health and Human Services from issuing guidance intended to restrict access to COVID-19 monoclonal antibody therapies and other treatments.</title>
  </titles>
  <sponsor bioguide_id="D000619"/>
  <cosponsors>
    <cosponsor bioguide_id="B001295" joined="2022-02-07"/>
    <cosponsor bioguide_id="C001039" joined="2022-02-07"/>
    <cosponsor bioguide_id="F000446" joined="2022-02-07"/>
    <cosponsor bioguide_id="F000449" joined="2022-02-08"/>
    <cosponsor bioguide_id="G000597" joined="2022-02-07"/>
    <cosponsor bioguide_id="G000563" joined="2022-02-08"/>
    <cosponsor bioguide_id="G000546" joined="2022-02-07"/>
    <cosponsor bioguide_id="G000576" joined="2022-02-09"/>
    <cosponsor bioguide_id="J000020" joined="2022-02-09"/>
    <cosponsor bioguide_id="L000564" joined="2022-02-07"/>
    <cosponsor bioguide_id="M000317" joined="2022-02-07"/>
    <cosponsor bioguide_id="M001180" joined="2022-02-08"/>
    <cosponsor bioguide_id="S001195" joined="2022-03-17"/>
    <cosponsor bioguide_id="T000478" joined="2022-02-07"/>
    <cosponsor bioguide_id="V000133" joined="2022-02-08"/>
    <cosponsor bioguide_id="V000134" joined="2022-02-07"/>
  </cosponsors>
  <actions>
    <action datetime="2022-02-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-02-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-02-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Civil actions and liability"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug therapy"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Federal officials"/>
    <term name="Government liability"/>
    <term name="Health care coverage and access"/>
    <term name="Health facilities and institutions"/>
    <term name="Health programs administration and funding"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Minority health"/>
    <term name="Racial and ethnic relations"/>
  </subjects>
  <amendments/>
  <summary date="2022-05-23T21:39:36Z" status="Introduced in House">Equal Access to Therapeutics Act

This bill prohibits using race or ethnicity as a factor in decisions about an individual's access to COVID-19 treatments (e.g., monoclonal antibody therapies).

Specifically, the Department of Health and Human Services (HHS) may not adopt any policy or guidance that allows race or ethnicity to be factored into such decisions. Furthermore, the Secretary of HHS shall be personally liable for the death of any individual who is denied access to COVID-19 treatments pursuant to a prohibited policy or guidance.

The bill also prohibits hospitals or other health care providers that have policies restricting access to COVID-19 treatments based on race or ethnicity from receiving federal funds.</summary>
</bill>
